Boston Scientific Asserts Stent Patents In Netherlands

Law360, New York (December 13, 2005, 12:00 AM EST) -- Medical device maker Boston Scientific has filed a patent infringement suit against Singapore-based Biosensors Group in a Dutch court, adding another lawsuit to the extensive litigation over highly profitable stent patents.

Boston Scientific and Canadian drug company Angiotech Pharmaceuticals have filed a suit against Biosensors, alleging the company’s drug eluding stent Axxion infringes patents controlled jointly by the two companies.

Biosensors said in a statement that despite the claims of the companies, its Dutch unit Occam International had received permission to sell its stents in Europe....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.